Drug-induced movement disorders

Bibliography

• Burkhard PR. Acute and subacute drug-induced movement disorders. Parkinsonism Relat Disord 2014;20:S108-12
   PubMedGoogle Scholar
• Jimenez-Jimenez FJ, Garcia-Ruiz PJ, Molina JA. Drug-induced movement disorders. Drug Saf 1997;16:180-204
   PubMed Web of Science ®Google Scholar
• Grant MJ, Booth A. A typology of reviews: an analysis of 14 review types and associated methodologies. Health Info Libr J 2009;26:91-108
   PubMed Web of Science ®Google Scholar
• Waln O, Jankovic J. An update on tardive dyskinesia: from phenomenology to treatment. Tremor Other Hyperkinet Mov (N Y) 2013;3:e1-11
   Google Scholar
• Cloud LJ, Zutshi D, Factor SA. Tardive dyskinesia: therapeutic options for an increasingly common disorder. Neurotherapeutics 2014;11:166-76
   PubMed Web of Science ®Google Scholar
• Woerner MG, Alvir JM, Saltz BL, et al. Prospective study of tardive dyskinesia in the elderly: rates and risk factors. Am J Psychiatry 1998;155:1521-8
   PubMed Web of Science ®Google Scholar
• Jeste DV, Caligiuri MP, Paulsen JS, et al. Risk of tardive dyskinesia in older patients. A prospective longitudinal study of 266 outpatients. Arch Gen Psychiatry 1995;52:756-65
   PubMed Web of Science ®Google Scholar
• Wonodi I, Adami HM, Cassady SL, et al. Ethnicity and the course of tardive dyskinesia in outpatients presenting to the motor disorders clinic at the Maryland psychiatric research center. J Clin Psychopharmacol 2004;24:592-8
   PubMed Web of Science ®Google Scholar
• Woerner MG, Saltz BL, Kane JM, et al. Diabetes and development of tardive dyskinesia. Am J Psychiatry 1993;150:966-8
   PubMed Web of Science ®Google Scholar
• Goyal R, Devi SH. A case of aripiprazole induced tardive dyskinesia in a neuroleptic-naive patient with two years of follow up. Clin Psychopharmacol Neurosci 2014;12:69-71
   PubMed Web of Science ®Google Scholar
• Albayrak Y, Ekinci O. Duloxetine-associated tardive dyskinesia resolved with fluvoxamine: a case report. J Clin Psychopharmacol 2012;32:723-4
   PubMed Web of Science ®Google Scholar
• Mark MH, Sage JI. Levodopa-associated hemifacial dystonia. Mov Disord 1991;6:383
   PubMed Web of Science ®Google Scholar
• Chakrabarti S, Chand PK. Lithium - induced tardive dystonia. Neurol India 2002;50:473-5
   PubMed Web of Science ®Google Scholar
• Fabiani G, Pastro PC, Froehner C. Parkinsonism and other movement disorders in outpatients in chronic use of cinnarizine and flunarizine. Arq Neuropsiquiatr 2004;62:784-8
   PubMed Web of Science ®Google Scholar
• Kane JM, Smith JM. Tardive dyskinesia: prevalence and risk factors, 1959 to 1979. Arch Gen Psychiatry 1982;39:473-81
   PubMed Web of Science ®Google Scholar
• Mejia NI, Jankovic J. Tardive dyskinesia and withdrawal emergent syndrome in children. Expert Rev Neurother 2010;10:893-901
   PubMed Web of Science ®Google Scholar
• Damier P. Drug-induced dyskinesias. Curr Opin Neurol 2009;22:394-9
   PubMed Web of Science ®Google Scholar
• Kenney C, Jankovic J. Tetrabenazine in the treatment of hyperkinetic movement disorders. Expert Rev Neurother 2006;6:7-17
   PubMedGoogle Scholar
• Aia PG, Revuelta GJ, Cloud LJ, Factor SA. Tardive dyskinesia. Curr Treat Options Neurol 2011;13:231-41
   PubMed Web of Science ®Google Scholar
• Fernandez HH, Friedman JH. Classification and treatment of tardive syndromes. Neurologist 2003;9:16-27
   PubMed Web of Science ®Google Scholar
• Factor SA. Propranolol therapy for tardive dyskinesia revisited. Mov Disord 2012;27:1703
   PubMed Web of Science ®Google Scholar
• Woods SW, Saksa JR, Baker CB, et al. Effects of levetiracetam on tardive dyskinesia: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry 2008;69:546-54
   PubMed Web of Science ®Google Scholar
• Hennings JM, Krause E, Botzel K, Wetter TC. Successful treatment of tardive lingual dystonia with botulinum toxin: case report and review of the literature. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:1167-71
   PubMed Web of Science ®Google Scholar
• Damier P, Thobois S, Witjas T, et al. Bilateral deep brain stimulation of the globus pallidus to treat tardive dyskinesia. Arch Gen Psychiatry 2007;64:170-6
   PubMed Web of Science ®Google Scholar
• Zhang JG, Zhang K, Wang ZC. Deep brain stimulation in the treatment of tardive dystonia. Chin Med J (Engl) 2006;119:789-92
   PubMed Web of Science ®Google Scholar
• Simpson GM, Lee JH, Shrivastava RK. Clozapine in tardive dyskinesia. Psychopharmacology (Berl) 1978;56:75-80
   PubMed Web of Science ®Google Scholar
• Bhidayasiri R, Fahn S, Weiner WJ, et al. Evidence-based guideline: treatment of tardive syndromes: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2013;81:463-9
   PubMed Web of Science ®Google Scholar
• Lopez-Sendon J, Mena MA, de Yebenes JG. Drug-induced parkinsonism. Expert Opin Drug Saf 2013;12:487-96
   PubMed Web of Science ®Google Scholar
• Vecsei L. Recent advances in Parkinson’s disease. Ideggyogy Sz 2002;55:406-7
   PubMedGoogle Scholar
• Barbosa MT, Caramelli P, Maia DP, et al. Parkinsonism and Parkinson’s disease in the elderly: a community-based survey in Brazil (the Bambui study). Mov Disord 2006;21:800-8
   PubMed Web of Science ®Google Scholar
• Brigo F, Erro R, Marangi A, et al. Differentiating drug-induced parkinsonism from Parkinson’s disease: an update on non-motor symptoms and investigations. Parkinsonism Relat Disord 2014;20:808-14
   PubMed Web of Science ®Google Scholar
• Lopez-Sendon JL, Mena MA, de Yebenes JG. Drug-induced Parkinsonism in the elderly: incidence, management and prevention. Drugs Aging 2012;29:105-18
   PubMed Web of Science ®Google Scholar
• Kagi G, Bhatia KP, Tolosa E. The role of DAT-SPECT in movement disorders. J Neurol Neurosurg Psychiatry 2010;81:5-12
   PubMed Web of Science ®Google Scholar
• Vlaar AM, de Nijs T, Kessels AG, et al. Diagnostic value of 123I-ioflupane and 123I-iodobenzamide SPECT scans in 248 patients with Parkinsonian syndromes. Eur Neurol 2008;59:258-66
   PubMed Web of Science ®Google Scholar
• Bajaj N, Hauser RA, Grachev ID. Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of Parkinsonian syndromes. J Neurol Neurosurg Psychiatry 2013;84:1288-95
   PubMed Web of Science ®Google Scholar
• Kanyo B, Argyelan M, Dibo G, et al. [Imaging of dopamine transporter with Tc99m-Trodat-SPECT in movement disorders]. Ideggyogy Sz 2003;56:231-40
   PubMedGoogle Scholar
• Lee PH, Kim JS, Shin DH, et al. Cardiac 123I-MIBG scintigraphy in patients with drug induced Parkinsonism. J Neurol Neurosurg Psychiatry 2006;77:372-4
   PubMed Web of Science ®Google Scholar
• Lee PH, Yeo SH, Yong SW, Kim YJ. Odour identification test and its relation to cardiac 123I-metaiodobenzylguanidine in patients with drug induced Parkinsonism. J Neurol Neurosurg Psychiatry 2007;78:1250-2
   PubMed Web of Science ®Google Scholar
• Noyes K, Liu H, Holloway RG. What is the risk of developing Parkinsonism following neuroleptic use? Neurology 2006;66:941-3
   PubMed Web of Science ®Google Scholar
• Rochon PA, Stukel TA, Sykora K, et al. Atypical antipsychotics and Parkinsonism. Arch Intern Med 2005;165:1882-8
   PubMed Web of Science ®Google Scholar
• Lieberman JA, Tollefson G, Tohen M, et al. Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol. Am J Psychiatry 2003;160:1396-404
   PubMed Web of Science ®Google Scholar
• Friedman JH. Atypical antipsychotics in the EPS-vulnerable patient. Psychoneuroendocrinology 2003;28(Suppl 1):39-51
   PubMed Web of Science ®Google Scholar
• Moteshafi H, Stip E. Comparing tolerability profile of quetiapine, risperidone, aripiprazole and ziprasidone in schizophrenia and affective disorders: a meta-analysis. Expert Opin Drug Saf 2012;11:713-32
   PubMed Web of Science ®Google Scholar
• Farde L, Nordstrom AL, Wiesel FA, et al. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. Arch Gen Psychiatry 1992;49:538-44
   PubMed Web of Science ®Google Scholar
• Benazzi F. Side-effects of benzamide derivatives. Int J Geriatr Psychiatry 1997;12:132
   PubMed Web of Science ®Google Scholar
• Strang RR. Parkinsonism occurring during methyldopa therapy. Can Med Assoc J 1966;95:928-9
   PubMed Web of Science ®Google Scholar
• Giladi N, Melamed E. Levodopa therapy can ameliorate tetrabenazine-induced Parkinsonism. Mov Disord 1999;14:158-9
   PubMed Web of Science ®Google Scholar
• Terland O, Flatmark T. Drug-induced Parkinsonism: cinnarizine and flunarizine are potent uncouplers of the vacuolar H+-ATPase in catecholamine storage vesicles. Neuropharmacology 1999;38:879-82
   PubMed Web of Science ®Google Scholar
• Masmoudi K, Gras-Champel V, Masson H, Andrejak M. Parkinsonism and/or cognitive impairment with valproic acid therapy: a report of ten cases. Pharmacopsychiatry 2006;39:9-12
   PubMed Web of Science ®Google Scholar
• Dallocchio C, Mazzarello P. A case of Parkinsonism due to lithium intoxication: treatment with Pramipexole. J Clin Neurosci 2002;9:310-11
   PubMed Web of Science ®Google Scholar
• Dotti MT, Federico A. Amiodarone-induced Parkinsonism: a case report and pathogenetic discussion. Mov Disord 1995;10:233-4
   PubMed Web of Science ®Google Scholar
• Stadtland C, Erfurth A, Arolt V. De novo onset of Parkinson’s disease after antidepressant treatment with citalopram. Pharmacopsychiatry 2000;33:194-5
   PubMed Web of Science ®Google Scholar
• Pina Latorre MA, Modrego PJ, Rodilla F, et al. Parkinsonism and Parkinson’s disease associated with long-term administration of sertraline. J Clin Pharm Ther 2001;26:111-12
   PubMed Web of Science ®Google Scholar
• Lima MA, Maradei S, Maranhao Filho P. Cyclosporine-induced Parkinsonism. J Neurol 2009;256:674-5
   PubMed Web of Science ®Google Scholar
• Muller T, Kuhn W, Pohlau D, Przuntek H. Parkinsonism unmasked by lovastatin. Ann Neurol 1995;37:685-6
   PubMed Web of Science ®Google Scholar
• Sugiyama Y. [Parkinsonism induced by propiverine hydrochloride – report of 3 cases]. Rinsho Shinkeigaku 1997;37:873-5
   PubMedGoogle Scholar
• Fisher JF, Dewald J. Parkinsonism associated with intraventricular amphotericin B. J Antimicrob Chemother 1983;12:97-9
   PubMed Web of Science ®Google Scholar
• Marti Masso JF, Poza JJ. [Drug-induced or aggravated Parkinsonism: clinical signs and the changing pattern of implicated drugs]. Neurologia 1996;11:10-15
   PubMedGoogle Scholar
• Rollema H, Skolnik M, D’Engelbronner J, et al. MPP(+)-like neurotoxicity of a pyridinium metabolite derived from haloperidol: in vivo microdialysis and in vitro mitochondrial studies. J Pharmacol Exp Ther 1994;268:380-7
   PubMed Web of Science ®Google Scholar
• Onofrj M, Thomas A. Acute akinesia in Parkinson disease. Neurology 2005;64:1162-9
   PubMed Web of Science ®Google Scholar
• Morgan JC, Sethi KD. Drug-induced tremors. Lancet Neurol 2005;4:866-76
   PubMed Web of Science ®Google Scholar
• Sirisena D, Williams DR. My hands shake – classification and treatment of tremor. Aust Fam Physician 2009;38:678-83
   PubMed Web of Science ®Google Scholar
• Charness ME, Morady F, Scheinman MM. Frequent neurologic toxicity associated with amiodarone therapy. Neurology 1984;34:669-71
   PubMed Web of Science ®Google Scholar
• Patterson RG, Couchenour RL. Trimethoprim-sulfamethoxazole-induced tremor in an immunocompetent patients. Pharmacotherapy 1999;19:1456-8
   PubMed Web of Science ®Google Scholar
• Raethjen J, Lemke MR, Lindemann M, et al. Amitriptyline enhances the central component of physiological tremor. J Neurol Neurosurg Psychiatry 2001;70:78-82
   PubMed Web of Science ®Google Scholar
• Wernicke JF. The side effect profile and safety of fluoxetine. J Clin Psychiatry 1985;46:59-67
   PubMed Web of Science ®Google Scholar
• Gelenberg AJ, Jefferson JW. Lithium tremor. J Clin Psychiatry 1995;56:283-7
   PubMed Web of Science ®Google Scholar
• Karas BJ, Wilder BJ, Hammond EJ, Bauman AW. Valproate tremors. Neurology 1982;32:428-32
   PubMed Web of Science ®Google Scholar
• Nizet TA, Broeders ME, Folgering HT. Tremor side effects of salbutamol, quantified by a laser pointer technique. Respir Med 2004;98:844-50
   PubMed Web of Science ®Google Scholar
• Dworkin LA, Goldman RD, Zivin LS, Fuchs PC. Cerebellar toxicity following high-dose cytosine arabinoside. J Clin Oncol 1985;3:613-16
   PubMed Web of Science ®Google Scholar
• Chiruka S, Chapman CS. Severe tremors associated with use of thalidomide. Am J Hematol 2005;78:81-2
   PubMed Web of Science ®Google Scholar
• Kataria M, Traub M, Marsden CD. Extrapyramidal side-effects of metoclopramide. Lancet 1978;2:1254-5
   PubMed Web of Science ®Google Scholar
• Ahronheim JC. Metoclopramide and tremor. Ann Intern Med 1982;97:621
   PubMed Web of Science ®Google Scholar
• Beier C, Liebezeit B, Volkl TM, et al. [Attempted suicide with L-thyroxine in an adolescent girl]. Klin Padiatr 2006;218:34-7
   PubMed Web of Science ®Google Scholar
• Gijtenbeek JM, van den Bent MJ, Vecht CJ. Cyclosporine neurotoxicity: a review. J Neurol 1999;246:339-46
   PubMed Web of Science ®Google Scholar
• Pataki CS, Carlson GA, Kelly KL, et al. Side effects of methylphenidate and desipramine alone and in combination in children. J Am Acad Child Adolesc Psychiatry 1993;32:1065-72
   PubMed Web of Science ®Google Scholar
• Yen YC, Lung FW, Chong MY. Adverse effects of risperidone and haloperidol treatment in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2004;28:285-90
   PubMed Web of Science ®Google Scholar
• Lingjaerde O. Tetrabenazine (nitoman) in the treatment of psychoses. with a discussion on the central mode of action of tetrabenazine and reserpine. Acta Psychiatr Scand 1963;39(Suppl 170):1-109
   PubMedGoogle Scholar
• Stacy M, Jankovic J. Tardive tremor. Mov Disord 1992;7:53-7
   PubMed Web of Science ®Google Scholar
• Klivenyi P, Vecsei L. [Updates in practical neurology – I. The principles of modern levodopa therapy in Parkinson’s disease]. Ideggyogy Sz 2007;60:61-4
   PubMedGoogle Scholar
• Gardian G, Vecsei L. Medical treatment of Parkinson’s disease: today and the future. Int J Clin Pharmacol Ther 2010;48:633-42
   PubMed Web of Science ®Google Scholar
• Ahlskog JE, Muenter MD. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord 2001;16:448-58
   PubMed Web of Science ®Google Scholar
• Schrag A, Quinn N. Dyskinesias and motor fluctuations in Parkinson’s disease. A community-based study. Brain 2000;123(Pt 11):2297-305
   PubMed Web of Science ®Google Scholar
• Zadori D, Szalardy L, Toldi J, et al. Some molecular mechanisms of dopaminergic and glutamatergic dysfunctioning in Parkinson’s disease. J Neural Transm 2013;120:673-81
   PubMed Web of Science ®Google Scholar
• Bhidayasiri R, Truong DD. Chorea and related disorders. Postgrad Med J 2004;80:527-34
   PubMed Web of Science ®Google Scholar
• Shulman LM, Singer C, Weiner WJ. Phenytoin-induced focal chorea. Mov Disord 1996;11:111-14
   PubMed Web of Science ®Google Scholar
• Zesiewicz TA, Sullivan KL. Drug-induced hyperkinetic movement disorders by nonneuroleptic agents. Handb Clin Neurol 2011;100:347-63
   PubMedGoogle Scholar
• Chari S, Quraishi SH, Jainer AK. Fluoxetine-induced exacerbation of chorea in Huntington’s disease? A case report. Pharmacopsychiatry 2003;36:41-3
   PubMed Web of Science ®Google Scholar
• Pulsinelli WA, Hamill RW. Chorea complicating oral contraceptive therapy. Case report and review of the literature. Am J Med 1978;65:557-9
   PubMed Web of Science ®Google Scholar
• Robottom BJ, Weiner WJ. Chorea gravidarum. Handb Clin Neurol 2011;100:231-5
   PubMedGoogle Scholar
• Weiner WJ, Nausieda PA, Klawans HL. Methylphenidate-induced chorea: case report and pharmacologic implications. Neurology 1978;28:1041-4
   PubMed Web of Science ®Google Scholar
• Morgan JC, Winter WC, Wooten GF. Amphetamine-induced chorea in attention deficit-hyperactivity disorder. Mov Disord 2004;19:840-2
   PubMed Web of Science ®Google Scholar
• Horn S, Hinson M, Morrissey M, Goetz CG. Blinded evaluation for the frequency of chorea in dystonia patients both on and off anticholinergic medication. Mov Disord 2002;17:S276-7
   Web of Science ®Google Scholar
• Samie MR, Ashton AK. Choreoathetosis induced by cyproheptadine. Mov Disord 1989;4:81-4
   PubMed Web of Science ®Google Scholar
• Ellender TJ, Huerta-Ocampo I, Deisseroth K, et al. Differential modulation of excitatory and inhibitory striatal synaptic transmission by histamine. J Neurosci 2011;31:15340-51
   PubMed Web of Science ®Google Scholar
• Lussier D, Cruciani RA. Choreiform movements after a single dose of methadone. J Pain Symptom Manage 2003;26:688-91
   PubMed Web of Science ®Google Scholar
• Wedzicha JA, Gibb WR, Lees AJ. Chorea in digoxin toxicity. J Neurol Neurosurg Psychiatry 1984;47:419
   PubMed Web of Science ®Google Scholar
• Stemper B, Thurauf N, Neundorfer B, Heckmann JG. Choreoathetosis related to lithium intoxication. Eur J Neurol 2003;10:743-4
   PubMed Web of Science ®Google Scholar
• Necioglu Orken D, Yldrmak Y, Kenangil G, et al. Intrathecal methotrexate-induced acute chorea. J Pediatr Hematol Oncol 2009;31:57-8
   PubMed Web of Science ®Google Scholar
• Quinn AG, Ellis WR, Burn D, Cartlidge N. Chorea precipitated by sulphasalazine. BMJ 1991;302:1025
   PubMed Web of Science ®Google Scholar
• McHugh P. Acute choreoathetoid reaction to propofol. Anaesthesia 1991;46:425
   PubMed Web of Science ®Google Scholar
• van der Plas AA, van Rijn MA, van Hilten JJ. Baclofen-induced chorea in complex regional pain syndrome-related dystonia. Mov Disord 2010;25:959-60
   PubMed Web of Science ®Google Scholar
• Rybakowski JK, Vansteelandt K, Remlinger-Molenda A, et al. Extrapyramidal symptoms during treatment of first schizophrenia episode: results from EUFEST. Eur Neuropsychopharmacol 2014;24:1500-5
   PubMed Web of Science ®Google Scholar
• Pierre JM. Extrapyramidal symptoms with atypical antipsychotics: incidence, prevention and management. Drug Saf 2005;28:191-208
   PubMed Web of Science ®Google Scholar
• Arnone D, Hansen L, Kerr JS. Acute dystonic reaction in an elderly patient with mood disorder after titration of paroxetine: possible mechanisms and implications for clinical care. J Psychopharmacol 2002;16:395-7
   PubMed Web of Science ®Google Scholar
• de Medina A, Biasini O, Rivera A, Sampera A. Nifedipine and myoclonic dystonia. Ann Intern Med 1986;104:125
   PubMed Web of Science ®Google Scholar
• Pina MA, Ara JR, Remirez A, Castiella J. Verapamil and acute dystonia. J Clin Pharm Ther 1998;23:79-80
   PubMed Web of Science ®Google Scholar
• Zesiewicz TA, Hauser RA, Freeman A, et al. Fentanyl-induced bradykinesia and rigidity after deep brain stimulation in a patient with Parkinson disease. Clin Neuropharmacol 2009;32:48-50
   PubMed Web of Science ®Google Scholar
• Gay CT, Ryan SG. Paroxysmal kinesigenic dystonia after methylphenidate administration. J Child Neurol 1994;9:45-6
   PubMed Web of Science ®Google Scholar
• Dhikav V, Anand KS. Acute dystonic reaction with rivastigmine. Int Psychogeriatr 2013;25:1385-6
   PubMed Web of Science ®Google Scholar
• Schneider SA, Bhatia KP. Secondary dystonia-clinical clues and syndromic associations. J Mov Disord 2009;2:58-63
   Google Scholar
• Howrie DL, Rowley AH, Krenzelok EP. Benztropine-induced acute dystonic reaction. Ann Emerg Med 1986;15:594-6
   PubMed Web of Science ®Google Scholar
• Incecik F, Herguner MO, Ozcan K, Altunbasak S. Albendazole-induced dystonic reaction: a case report. Turk J Pediatr 2011;53:709-10
   PubMed Web of Science ®Google Scholar
• Lee JW. Persistent dystonia associated with carbamazepine therapy: a case report. N Z Med J 1994;107:360-1
   PubMedGoogle Scholar
• Esen I, Demirpence S, Yis U, Kurul S. Cetirizine-induced dystonic reaction in a 6-year-old boy. Pediatr Emerg Care 2008;24:627-8
   PubMed Web of Science ®Google Scholar
• Stolarek IH, Ford MJ. Acute dystonia induced by midazolam and abolished by flumazenil. BMJ 1990;300:614
   PubMed Web of Science ®Google Scholar
• Davis BJ, Aul EA, Granner MA, Rodnitzky RL. Ranitidine-induced cranial dystonia. Clin Neuropharmacol 1994;17:489-91
   PubMed Web of Science ®Google Scholar
• Brashear A, Siemers E. Focal dystonia after chemotherapy: a case series. J Neurooncol 1997;34:163-7
   PubMed Web of Science ®Google Scholar
• Wood N, Pall HS, Williams AC, Dieppe C. Extrapyramidal reactions to anti-inflammatory drugs. J Neurol Neurosurg Psychiatry 1988;51:731-2
   PubMed Web of Science ®Google Scholar
• Iselin-Chaves IA, Grotzsch H, Besson M, et al. Naloxone-responsive acute dystonia and Parkinsonism following general anaesthesia. Anaesthesia 2009;64:1359-62
   PubMed Web of Science ®Google Scholar
• Mazurek MF, Rosebush PI. A prospective study of neuroleptic-induced dystonia: incidence and relationship to age, sex, medications and concurrent Parkinsonism. Neurology 1991;41:S274
   Google Scholar
• Marion MH, Klap P, Perrin A, Cohen M. Stridor and focal laryngeal dystonia. Lancet 1992;339:457-8
   PubMed Web of Science ®Google Scholar
• Tan EK, Jankovic J. Tardive and idiopathic oromandibular dystonia: a clinical comparison. J Neurol Neurosurg Psychiatry 2000;68:186-90
   PubMed Web of Science ®Google Scholar
• van Gaalen J, Kerstens FG, Maas RP, et al. Drug-induced cerebellar ataxia: a systematic review. CNS Drugs 2014;28:1139-53
   PubMed Web of Science ®Google Scholar
• Pulce C, Mollon P, Pham E, et al. Acute poisonings with ethyle loflazepate, flunitrazepam, prazepam and triazolam in children. Vet Hum Toxicol 1992;34:141-3
   PubMedGoogle Scholar
• Kutt H, Winters W, Scherman R, McDowell F. Diphenylhydantoin and phenobarbital Toxicity. The role of liver disease. Arch Neurol 1964;11:649-56
   PubMed Web of Science ®Google Scholar
• Shaw SH, Curson H, Coquelin JP. A double-blind, comparative study of zolpidem and placebo in the treatment of insomnia in elderly psychiatric in-patients. J Int Med Res 1992;20:150-61
   PubMed Web of Science ®Google Scholar
• Krach LE. Pharmacotherapy of spasticity: oral medications and intrathecal baclofen. J Child Neurol 2001;16:31-6
   PubMed Web of Science ®Google Scholar
• Zaccara G, Cincotta M, Borgheresi A, Balestrieri F. Adverse motor effects induced by antiepileptic drugs. Epileptic Disord 2004;6:153-68
   PubMed Web of Science ®Google Scholar
• Dobrea C, Buoli M, Arici C, et al. Tolerability and use in co-administration of pregabalin in affective patients: a 6-month prospective naturalistic study. Expert Opin Drug Saf 2012;11:893-9
   PubMed Web of Science ®Google Scholar
• Steinhoff BJ, Herrendorf G, Bittermann HJ, Kurth C. Isolated ataxia as an idiosyncratic side-effect under gabapentin. Seizure 1997;6:503-4
   PubMed Web of Science ®Google Scholar
• Ghatak NR, Santoso RA, McKinney WM. Cerebellar degeneration following long-term phenytoin therapy. Neurology 1976;26:818-20
   PubMed Web of Science ®Google Scholar
• Hain TC, Cherchi M, Yacovino DA. Bilateral vestibular loss. Semin Neurol 2013;33:195-203
   PubMed Web of Science ®Google Scholar
• Ding D, Jiang H, Salvi RJ. Mechanisms of rapid sensory hair-cell death following co-administration of gentamicin and ethacrynic acid. Hear Res 2010;259:16-23
   PubMed Web of Science ®Google Scholar
• Lugassy G, Shapira A. A prospective cohort study of the effect of vincristine on audition. Anticancer Drugs 1996;7:525-6
   PubMed Web of Science ®Google Scholar
• Camdessanche JP, Jousserand G, Ferraud K, et al. The pattern and diagnostic criteria of sensory neuronopathy: a case-control study. Brain 2009;132:1723-33
   PubMed Web of Science ®Google Scholar
• Gaist D, Jeppesen U, Andersen M, et al. Statins and risk of polyneuropathy: a case-control study. Neurology 2002;58:1333-7
   PubMed Web of Science ®Google Scholar
• Fraser AG, McQueen IN, Watt AH, Stephens MR. Peripheral neuropathy during longterm high-dose amiodarone therapy. J Neurol Neurosurg Psychiatry 1985;48:576-8
   PubMed Web of Science ®Google Scholar
• Dalakas MC. Peripheral neuropathy and antiretroviral drugs. J Peripher Nerv Syst 2001;6:14-20
   PubMed Web of Science ®Google Scholar
• Brefel-Courbon C, Gardette V, Ory F, Montastruc JL. Drug-induced myoclonus: a French pharmacovigilance database study. Neurophysiol Clin 2006;36:333-6
   PubMed Web of Science ®Google Scholar
• Yoshida K, Moriwaka F, Matsuura T, et al. Myoclonus and seizures in a patient with Parkinsonism: induction by levodopa and its confirmation on SEPs. Jpn J Psychiatry Neurol 1993;47:621-5
   PubMedGoogle Scholar
• Fukuzako H, Tominaga H, Izumi K, et al. Postural myoclonus associated with long-term administration of neuroleptics in schizophrenic patients. Biol Psychiatry 1990;27:1116-26
   PubMed Web of Science ®Google Scholar
• Lu CS, Chu NS. Acute dystonic reaction with asterixis and myoclonus following metoclopramide therapy. J Neurol Neurosurg Psychiatry 1988;51:1002-3
   PubMed Web of Science ®Google Scholar
• Bougea A, Gerakoulis S, Anagnostou E, et al. Donepezil-induced myoclonus in a patient with Alzheimer disease. Ann Pharmacother 2014;48:1659-61
   PubMed Web of Science ®Google Scholar
• Aguglia U, Zappia M, Quattrone A. Carbamazepine-induced nonepileptic myoclonus in a child with benign epilepsy. Epilepsia 1987;28:515-18
   PubMed Web of Science ®Google Scholar
• Wallace EL, Lingle K, Pierce D, Satko S. Amlodipine-induced myoclonus. Am J Med 2009;122:e7
   PubMed Web of Science ®Google Scholar
• Deik AF, Shanker VL. A case of amiodarone-associated myoclonus responsive to levetiracetam. Can J Neurol Sci 2012;39:680-1
   PubMed Web of Science ®Google Scholar
• Lazar A, Mau-Holzmann UA, Kolb H, et al. Multiple organ failure due to 5-fluorouracil chemotherapy in a patient with a rare dihydropyrimidine dehydrogenase gene variant. Onkologie 2004;27:559-62
   PubMed Web of Science ®Google Scholar
• Alcalay M, Thomas P, Reboux JF, Bontoux D. [Myoclonus during a treatment with diclofenac (author’s transl)]. Sem Hop 1979;55:679-80
   PubMedGoogle Scholar
• Isitemiz I, Uzman S, Toptas M, et al. Prevention of etomidate-induced myoclonus: which is superior: fentanyl, midazolam, or a combination? A Retrospective comparative study. Med Sci Monit 2014;20:262-7
   PubMed Web of Science ®Google Scholar
• Tominaga H, Fukuzako H, Izumi K, et al. Tardive myoclonus. Lancet 1987;1:322
   PubMed Web of Science ®Google Scholar
• Gadow KD, Sverd J, Sprafkin J, et al. Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder. Arch Gen Psychiatry 1999;56:330-6
   PubMed Web of Science ®Google Scholar
• Altindag A, Yanik M, Asoglu M. The emergence of tics during escitalopram and sertraline treatment. Int Clin Psychopharmacol 2005;20:177-8
   PubMed Web of Science ®Google Scholar
• Bharucha KJ, Sethi KD. Tardive tourettism after exposure to neuroleptic therapy. Mov Disord 1995;10:791-3
   PubMed Web of Science ®Google Scholar
• Neglia JP, Glaze DG, Zion TE. Tics and vocalizations in children treated with carbamazepine. Pediatrics 1984;73:841-4
   PubMed Web of Science ®Google Scholar
• Kane JM, Fleischhacker WW, Hansen L, et al. Akathisia: an updated review focusing on second-generation antipsychotics. J Clin Psychiatry 2009;70:627-43
   PubMed Web of Science ®Google Scholar
• Koliscak LP, Makela EH. Selective serotonin reuptake inhibitor-induced akathisia. J Am Pharm Assoc (2003) 2009;49:e28-36. quiz e37-8
   PubMed Web of Science ®Google Scholar
• Yazici KU, Percinel I. Atomoxetine-associated akathisia: a case report. J Clin Psychopharmacol 2014;34:770-2
   PubMed Web of Science ®Google Scholar
• Gurrera RJ, Caroff SN, Cohen A, et al. An international consensus study of neuroleptic malignant syndrome diagnostic criteria using the Delphi method. J Clin Psychiatry 2011;72:1222-8
   PubMed Web of Science ®Google Scholar
• Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med 2005;352:1112-20
   PubMed Web of Science ®Google Scholar
• Hoque R, Chesson ALJr. Pharmacologically induced/exacerbated restless legs syndrome, periodic limb movements of sleep, and REM behavior disorder/REM sleep without atonia: literature review, qualitative scoring, and comparative analysis. J Clin Sleep Med 2010;6:79-83
   PubMed Web of Science ®Google Scholar
• Brown LK, Dedrick DL, Doggett JW, Guido PS. Antidepressant medication use and restless legs syndrome in patients presenting with insomnia. Sleep Med 2005;6:443-50
   PubMed Web of Science ®Google Scholar
• Terao T, Terao M, Yoshimura R, Abe K. Restless legs syndrome induced by lithium. Biol Psychiatry 1991;30:1167-70
   PubMed Web of Science ®Google Scholar
• Santamaria J, Iranzo A, Tolosa E. Development of restless legs syndrome after dopaminergic treatment in a patient with periodic leg movements in sleep. Sleep Med 2003;4:153-5
   PubMed Web of Science ®Google Scholar
• Tan EK, Ho SC, Koh L, Pavanni R. An urge to move with L-thyroxine: clinical, biochemical, and polysomnographic correlation. Mov Disord 2004;19:1365-7
   PubMed Web of Science ®Google Scholar
• Kraus T, Schuld A, Pollmacher T. Periodic leg movements in sleep and restless legs syndrome probably caused by olanzapine. J Clin Psychopharmacol 1999;19:478-9
   PubMed Web of Science ®Google Scholar
• Rittmannsberger H, Werl R. Restless legs syndrome induced by quetiapine: report of seven cases and review of the literature. Int J Neuropsychopharmacol 2013;16:1427-31
   PubMed Web of Science ®Google Scholar
• Drake ME. Restless legs with antiepileptic drug therapy. Clin Neurol Neurosurg 1988;90:151-4
   PubMed Web of Science ®Google Scholar
• O’Sullivan RL, Greenberg DB. H2 antagonists, restless leg syndrome, and movement disorders. Psychosomatics 1993;34:530-2
   PubMed Web of Science ®Google Scholar
• Vetrugno R, La Morgia C, D’Angelo R, et al. Augmentation of restless legs syndrome with long-term tramadol treatment. Mov Disord 2007;22:424-7
   PubMed Web of Science ®Google Scholar
• Ware JC, Brown FW, Moorad PJ, et al. Nocturnal myoclonus and tricyclic antidepressants. Sleep Res 1984;13:72
   Google Scholar
• Winkelman JW, James L. Serotonergic antidepressants are associated with REM sleep without atonia. Sleep 2004;27:317-21
   PubMed Web of Science ®Google Scholar
• Louden MB, Morehead MA, Schmidt HS. Activation by selegiline (Eldepryle) of REM sleep behavior disorder in Parkinsonism. W V Med J 1995;91:101
   PubMedGoogle Scholar
• Iranzo A, Santamaria J. Bisoprolol-induced rapid eye movement sleep behavior disorder. Am J Med 1999;107:390-2
   PubMed Web of Science ®Google Scholar
• Kizilay F, Ekmekci B, Gungor H, et al. Flunarizine-induced fasciculation-myokymia. J Clin Neuromuscul Dis 2011;12:246-7
   PubMedGoogle Scholar
• Gangireddy VG, Mitchell LC, Coleman T. Cefepime neurotoxicity despite renal adjusted dosing. Scand J Infect Dis 2011;43:827-9
   PubMed Web of Science ®Google Scholar
• Nicholson D, Scalettar R, Jacobs RP. Rheumatoid rigor: gold induced myokymia. A report and review of the literature. J Rheumatol 1986;13:195-6
   PubMed Web of Science ®Google Scholar
• Besser R, Luttgen N, Frieling T. Oxaliplatin-induced hyperexcitability of the peripheral nerves. Klin Neurophysiol 2005;36:121-4
   Web of Science ®Google Scholar
• Teravainen H, Makitie J. Myokymia, unusual side-effect of clofibrate. Lancet 1976;2:1298
   PubMed Web of Science ®Google Scholar
• Tan EK, Chan LL, Lo YL. “Myorhythmia” slow facial tremor from chronic interferon alpha-2a usage. Neurology 2003;61:1302-3
   PubMed Web of Science ®Google Scholar